Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir-Reference-Cited by-同舟云学术

Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir

Published:2012-07-17 Issue:11 Volume:26 Page:1371-1385
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

McComsey Grace A.,Kitch Douglas,Daar Eric S.,Tierney Camlin,Jahed Nasreen C.,Melbourne Kathleen,Ha Belinda,Brown Todd T.,Bloom Anthony,Fedarko Neal,Sax Paul E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference35 articles.

1. Tumor necrosis factor (TNF) system levels in human immunodeficiency virus-infected patients during highly active antiretroviral therapy: persistent TNF activation is associated with virologic and immunologic treatment failure.;Aukrust;J Infect Dis,1999

2. C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056 s.;Henry;AIDS,2004

3. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.;Ross;Clin Infect Dis,2009

4. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients; Strategies for Management of Anti-Retroviral TherapyINSIGHT; DAD Study Study Groups.;Lundgren;AIDS,2008

5. Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study.;Worm;J Infect Dis,2010

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Modern ART Regimens and Immunosenescence Markers in Patients with Chronic HIV Infection;Viruses;2024-07-26

2. Serum uric acid and high-sensitivity C-reactive protein levels among people living with HIV on dolutegravir and ritonavir-boosted atazanavir-based antiretroviral therapy: a comparative cross-sectional study;Frontiers in Medicine;2024-07-17

3. Observational study of effects of HIV acquisition and antiretroviral treatment on biomarkers of systemic immune activation;PLOS ONE;2024-07-08

4. Long-term effects on subclinical cardiovascular disease of switching from boosted protease inhibitors to dolutegravir;Journal of Antimicrobial Chemotherapy;2023-08-04

5. Observational study of effects of HIV Acquisition and Antiretroviral Treatment on Biomarkers of Systemic Immune Activation;2023-07-08